닥플 플러스
KATRDIC 2026 (제142차 추계학술대회) 3일차
대한결핵및호흡기학회
연수평점 :6점
오프라인
주관
대한결핵및호흡기학회
교육일자
2026-10-30
수강료
300,000원
교육형태
오프라인
등록일시
2026-09-14
교육시간
20시간
연수평점
6점
장소
서울특별시 롯데호텔월드
교육종류
내과, 의학교육
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-10-30 | 08:30~09:00 | GOLD: Evolution and Annual Updates—Implementation and the Road Ahead | Claus F. Vogelmeier(Philipps-University Marburg) | - |
| 2026-10-30 | 09:00~09:30 | The Modern Management of Malignant Pleural Effusions - European Perspectives | Rahul Bhatnagar(University of Bristol) | - |
| 2026-10-30 | 09:30~10:00 | Deciphering the Development and Metastatic Progression of EGFR-Mutant Lung Cancer | 이재철(울산의대) | - |
| 2026-10-30 | 10:00~10:20 | Break | - | - |
| 2026-10-30 | 10:20~10:45 | Sputum Culture Conversion in NTM Pulmonary Disease: Still the Most Important Goal | 조경욱(울산의대) | - |
| 2026-10-30 | 10:45~11:10 | What Patients Actually Experience: PROs, Quality of Life, and Nutritional Status in NTM-PD | 박영목(연세의대) | - |
| 2026-10-30 | 11:10~11:35 | The Economic Burden of NTM-PD: Implications for Clinical Decision-Making | 황현택(서울의대) | - |
| 2026-10-30 | 11:35~11:50 | Q&A, Discussion | - | - |
| 2026-10-30 | 11:50~12:20 | New Paradigm of Exacerbation-risk Assessment | Claus F. Vogelmeier(Philipps-University Marburg) | - |
| 2026-10-30 | 12:20~14:40 | Break | - | - |
| 2026-10-30 | 14:40~15:05 | Fraily, Performance, and Prognosis in COPD | 안태준(가톨릭의대) | - |
| 2026-10-30 | 15:05~15:30 | Imaging and Functional Links in COPD: Muscle, Exercise, and Hyperinflation | Yasutaka Nakano(Shiga University of Medical Science) | - |
| 2026-10-30 | 15:30~15:55 | From Monitoring to Intervention: Digital Biomarkers in the Understanding, Detection, and Early Management of Exacerbations of COPD | Bryan Ross(McGill University) | - |
| 2026-10-30 | 15:55~16:10 | Q&A, Discussion | - | - |
| 2026-10-30 | 16:10~16:20 | Break | - | - |
| 2026-10-30 | 16:20~16:45 | Endophenotyping of OSA: Linking Mechanisms to Targeted Therapies | Ali Azarbarzin(Harvard Medical School) | - |
| 2026-10-30 | 16:45~17:10 | Phenotyping, Predicting and Personalizing: The Future of Oral Appliance Therapy for Obstructive Sleep Apnea | Andrew Chan(The University of Sydney) | - |
| 2026-10-30 | 17:10~17:35 | Pharmacologic Therapies for OSA: Lessons from Landmark RCTs and How to Apply to Phenotyping | 조영재(서울의대) | - |
| 2026-10-30 | 17:35~17:50 | Q&A, Discussion | - | - |
| 2026-10-30 | 10:20~10:45 | AI and Digital Transformation in the ICU: Korean Experience | 고태훈(가톨릭의대) | - |
| 2026-10-30 | 10:45~11:10 | New SSC Guidelines: Asian Perspective (or Focused on Pulmonary Sepsis) | 고령은(성균관의대) | - |
| 2026-10-30 | 11:10~11:35 | Regional Collaboration for Critical Care Medicine in the Asia-Pacific Region, Challenges and Opportunities | Ming-Cheng Chan(Taichung Veterans General Hospital) | - |
| 2026-10-30 | 11:35~11:50 | Q&A, Discussion | - | - |
| 2026-10-30 | 11:50~12:20 | Precision Treatment in COPD: Identifying Patients Most Likely to Benefit | Mona Bafadhel(King's College London) | - |
| 2026-10-30 | 12:20~14:40 | Break | - | - |
| 2026-10-30 | 14:40~15:05 | Pulmonary Alveolar Proteinosis: Old Disease, New Insights | Toru Arai(National Hospital Organization Kinki-Chuo Chest Medical Center) | - |
| 2026-10-30 | 15:05~15:30 | Advances in LAM Management: Evidence from Recent Research | Ian Glaspole(The Alfred Hospital) | - |
| 2026-10-30 | 15:30~15:55 | PPFE: Clinical Insights and Emerging Concepts | 최혜숙(경희의대) | - |
| 2026-10-30 | 15:55~16:10 | Q&A, Discussion | - | - |
| 2026-10-30 | 16:10~16:20 | Break | - | - |
| 2026-10-30 | 16:20~16:45 | Multicenter Real-World Experience of Managing MDR-GNB in East Asia: The Taiwan Experience | Chung-Kan Peng(Hualien Armed Forces General Hospital) | - |
| 2026-10-30 | 16:45~17:10 | Multicenter Real-World Experience of Managing MDR-GNB in East Asia: The Korean Experience | 장유진(가톨릭대학교) | - |
| 2026-10-30 | 17:10~17:35 | Precision Antibiotic Stewardship: Selecting the Right Agent for MDR-GNB in the Era of New Drugs | 허경민(성균관의대) | - |
| 2026-10-30 | 17:35~17:50 | Q&A, Discussion | - | - |
| 2026-10-30 | 10:20~10:45 | Implementation of Lung Cancer Screening for Never-Smokers | Pan-Chyr Yang(National Taiwan University College of Medicine) | - |
| 2026-10-30 | 10:45~11:10 | Risk Prediction Models for Personalized Lung Cancer Screening | 김연욱(서울의대) | - |
| 2026-10-30 | 11:10~11:35 | Emerging Biomarkers for Early Detection of Lung Cancer: What Could Replace Current Standard? | 정재욱(충남의대) | - |
| 2026-10-30 | 11:35~11:50 | Q&A, Discussion | - | - |
| 2026-10-30 | 11:50~12:20 | Lazertinib: A Key Pillar in First-Line EGFRm+ NSCLC - Powerful as One, Stronger as Two | 임정욱(가톨릭의대) | - |
| 2026-10-30 | 12:20~14:40 | Break | - | - |
| 2026-10-30 | 14:40~15:05 | Optimizing Anticoagulation in Cancer-Associated VTE: Balancing Recurrence and Bleeding | Lai Heng Lee(Singapore General Hospital) | - |
| 2026-10-30 | 15:05~15:30 | Navigating Periprocedural DOAC Management: From Evidence to Practice | 허진영(중앙의대) | - |
| 2026-10-30 | 15:30~15:55 | Obstructive Sleep Apnea in Pulmonary Hypertension: An Overlooked Contributor | 강지은(서울의대) | - |
| 2026-10-30 | 15:55~16:10 | Q&A, Discussion | - | - |
| 2026-10-30 | 16:10~16:20 | Break | - | - |
| 2026-10-30 | 16:20~16:45 | Tuberculosis in Malaysia: Epidemiology, Drug Resistance, and the Unmet Need for Scalable Screening | Ahmad Izuanuddin Ismail(Hospital Al Sultan Abdullah Universiti Teknologi MARA) | - |
| 2026-10-30 | 16:45~17:10 | Latent Tuberculosis Infection in Malaysia: Diagnosis, Treatment, and the Gap Between Guidelines and Reality | Arvindran Alaga(Head, Clinical & Interventional Pulmonology, Hospital Sultanah Bahiyah, Alor Setar) | - |
| 2026-10-30 | 17:10~17:35 | Korea’s Journey in Tuberculosis Control: From High-Burden Nation to Elimination Policy and Remaining Challenge | 김태화(고신대학교) | - |
| 2026-10-30 | 17:35~17:50 | Q&A, Discussion | - | - |
| 2026-10-30 | 11:50~12:20 | Clinical Proof of Better Cough Outcomes in Acute Bronchitis | 최준영(가톨릭의대) | - |
| 2026-10-30 | 12:20~14:40 | Break | - | - |
| 2026-10-30 | 14:40~15:10 | Anti-Tuberculosis Drug Resistance in Korea and Future Directions for Drug Susceptibility Testing | 이경인(대한결핵협회 결핵연구원) | - |
| 2026-10-30 | 15:10~15:40 | Current Status of Tuberculosis in Korea: Insights from PPM-Based Big Data Analysis | 오지연(고려의대) | - |
| 2026-10-30 | 15:40~16:10 | 국가 결핵관리사업의 성과와 향후 계획 | 김지영(질병관리청) | - |
| 2026-10-30 | 16:10~16:20 | Break | - | - |
| 2026-10-30 | 16:20~16:50 | TB vs. NTM: Look-Alikes, but Not the Same | 전병우(성균관의대) | - |
| 2026-10-30 | 16:50~17:20 | Latest Updates in the Diagnosis and Treatment of Latent Tuberculosis Infection | 박희문(서울의대) | - |
| 2026-10-30 | 17:20~17:50 | MDR/RR-TB의 진단, 치료 최신 지견 | 김형우(가톨릭의대) | - |
비고
Early Registration / On-site Registration/One-day Registration : Medical Doctor, Professor - 250,000원 / 300,000원 / 180,000원Fellow, Nurse, Military, Doctor, Researcher - 150,000원/ 180,000원 / 100,000원Resident, Trainee, Student - 무료 Hands-on - 200,000원/ Not Applicable Meet the Expert - 20,000원
문의처
담당자
정혜선
연락처
02-575-3825
이메일
katrd@hanmail.net